key: cord-0830908-ugx7ndgp authors: Bouman, Judith A.; Kadelka, Sarah; Stringhini, Silvia; Pennacchio, Francesco; Meyer, Benjamin; Yerly, Sabine; Kaiser, Laurent; Guessous, Idris; Azman, Andrew S.; Bonhoeffer, Sebastian; Regoes, Roland R. title: Applying mixture model methods to SARS-CoV-2 serosurvey data from Geneva date: 2022-05-07 journal: Epidemics DOI: 10.1016/j.epidem.2022.100572 sha: f22c7bd549811c884c0cf91715e964955c449a35 doc_id: 830908 cord_uid: ugx7ndgp Serosurveys are an important tool to estimate the true extent of the current SARS-CoV-2 pandemic. So far, most serosurvey data have been analysed with cut-off based methods, which dichotomize individual measurements into sero-positives or negatives based on a predefined cutoff. However, mixture model methods can gain additional information from the same serosurvey data. Such methods refrain from dichotomizing individual values and instead use the full distribution of the serological measurements from pre-pandemic and COVID-19 controls to estimate the cumulative incidence. This study presents an application of mixture model methods to SARS-CoV-2 serosurvey data from the SEROCoV-POP study from April and May 2020 in Geneva (2766 individuals). Besides estimating the total cumulative incidence in these data (8.1% (95% CI: 6.8%–9.8%)), we applied extended mixture model methods to estimate an indirect indicator of disease severity, which is the fraction of cases with a distribution of antibody levels similar to hospitalised COVID-19 patients. This fraction is 51.2% (95% CI: 15.2%–79.5%) across the full serosurvey, but differs between three age classes: 21.4% (95% CI: 0%–59.6%) for individuals between 5 and 40 years old, 60.2% (95% CI: 21.5%–100%) for individuals between 41 and 65 years old and 100% (95% CI: 20.1%–100%) for individuals between 66 and 90 years old. Additionally, we find a mismatch between the inferred negative distribution of the serosurvey and the validation data of pre-pandemic controls. Overall, this study illustrates that mixture model methods can provide additional insights from serosurvey data. In this study, we apply mixture model methods to serosurvey data from the SEROCoV-POP study that was 76 performed in Geneva in April and May of 2020 [2] . In addition to corroborating previous estimates of the 77 cumulative incidence for these data (4.6 % in first week (95% CI: 2.4%-8.0%) to 10.9 % in the fifth week (95% 78 CI: 8.2%-13.9%)) -we estimated a cumulative incidence of 8.1% (95% CI: 6.8% -9.8%) over the whole period 79 of sampling -, our aim is to show how mixture model methods can be used to extract more information from 80 serosurveys. We use an extended mixture model that takes into consideration the distribution of antibody 81 levels of both hospitalized COVID-19 patients and outpatients. This results in an estimate of what we call the 82 indirect indicator of severity, which is defined as the fraction of individuals in the serosurvey that display a 83 distribution of antibody levels similar to that of the hospitalized patients in the control data. This fraction is 84 not a direct estimate of the fraction of cases in the serosurvey that were treated in a hospital, as the validation 85 data does not contain positive control data from asymptomatic and mild cases. Therefore, we rather refer to 86 this quantity as the indirect indicator of disease severity. The serological assay measurements for all sera in both datasets were obtained with the Euroimmun SARS- CoV-2 serological assay which quantifies the IgG anti-bodies against the S1-domain of the spike protein of 110 SARS-CoV-2 [14] . The IgG ratio is the result of the immunoreactivity of the sample measured at an optical 111 density of 450 nm (OD450) divided by the OD450 of the calibrator [14] , [19] . Mixture model methods 113 We have assembled all observations of the SEROCoV-POP study from April and May and apply the mixture OD ratios for the pre-pandemic and COVID-19 control measurements, and π is the cumulative incidence. The empirical distributions are obtained by smoothing the observed distributions. This is done with the 120 'density'-function in R using the default kernel setting, 'gaussian'. [20] . The use of this smoothing function has 121 been validated with simulated data in Bouman et al [8] . The specific smoothing algorithm does influence the 122 results, even though the differences are small. For example, the kernel 'cosine' results in a point estimate of 123 the cumulative incidence of 8.7 % (95%CI : 6.9% − 10.3%). More extensive data would allow us to determine 124 the antibody distribution more reliable. The likelihood is extended for the model where the outpatient and hospitalized cases are estimated separately, 126 see equation 2. Here, π out is the cumulative incidence of outpatient cases and π hosp the cumulative incidence 127 of hospitalized cases, σ i can be 0 (no past infection), 1 (past outpatient infection) or 2 (past hospitalized 128 infection). The 95% confidence intervals are estimated by bootstrapping the control distributions as well as the observa- We have also used an adjusted version of the method described above, where we summarized all obser- [14] . Solid lines indicate the empirical distributions. The purple solid line shows the inferred additional distribution that is an indication of the mismatch between the pre-pandemic controls and the serosurvey data. To investigate if the model improves by including a separate estimate for both types of positive controls, we 174 compared the likelihood of the estimates above to the likelihood from a model that is based on either the 175 hospitalized or outpatient control data only (see Equation 1 and Table 1 ). The p-values in Table 1 indicate 176 that the model is indeed significantly improved by estimating two cumulative incidences separately. Table 1 177 also shows that the point estimate of the total cumulative incidence estimate is higher if the mixture model is 178 based on the outpatient controls only and lower if it is based on the hospitalized controls only, compared to 179 the model that uses both distributions. This is expected, as the distribution obtained from the COVID-19 180 hospitalized controls is more distinguishable from the pre-pandemic controls than the COVID-19 outpatient 181 controls. Indirect indicator of disease severity differs between age groups 183 It is known that there is a correlation between the age of an infected individual and the severity of a SARS- CoV-2 infection [21] . To validate our methodology, we estimated the indirect indicator of disease severity for 185 three age-classes: 5 to 40 years, 41 to 65 years and 66 to 90 years. These estimates, together with the total 186 cumulative incidence estimates for the age-classes, are shown in Table 2 . Indeed, the indirect indicator of 187 disease severity is highest for the oldest age class: we estimated that 100 % of the cases in the serosurvey can 188 be explained by the distribution of the hospitalized COVID-19 controls, for the middle and young class this 189 is 60.2 % and 21.4 % respectively (see Figure 2) . Figure 3 shows that the maximal observed IgG ratio as Hospitalized data only 7.7% (6.3% -9.6%) 5.0e-07 Outpatient and hospitalized data treated as separate distributions 8.1% (6.8% -9.9%) - The total cumulative incidence of SARS-CoV-2 infections for the model that includes the additional case 220 distribution is 9.3% (95% CI: 6.7% -10.6 %) and thus higher than without this distribution. The reason for 221 this is that the additional distribution is on the lower range of the observed IgG OD Ratio, hence some of the 222 lower range values from the serosurvey data are now inferred to be similar to the additional distribution and 223 thus also COVID-19 cases. In this study, we present an application of mixture model methods to SARS-CoV-2 serosurvey data. Serosurvey 240 data are currently used to determine the proportion of seropositivity and to estimate the cumulative incidence 241 and the relative risk of seropositivity in various sub-groups. This is usually done by introducing a cutoff for 242 seropositivity. We show that mixture models that use the entire distribution of the antibody levels rather than a cut- Other studies using mixture model methods to analyse SARS-CoV-2 serosurvey data have been conducted. pandemic. Current estimates of antibody half lives IgG RBD are around 50-106 days [25] . Therefore we expect the effect of sero-reversion to be negligible. Furthermore, we did not correct the estimate of cumulative 269 incidence for age nor household structure because our study was aiming to provide a proof of concept rather when asymptomatic and mild cases often go undetected and their proportion is unknown. Part of the aim of our approach was to identify potential biases caused by any of the mentioned limi-298 tations in the validation data. Interestingly, however, the mismatch we identify is not characterized by an 299 intermediate level of antibodies in between the level of the pre-pandemic sera and the outpatients as we 300 would expect for a missing distribution of mild or asymptotic cases. Opposite to our expectation we found 301 that the serosurvey data display a narrower distribution at the lower end of the antibody levels than the 302 pre-pandemic, negative controls -as if there were asymptotic or mild SARS-CoV-2 infections among the 303 pre-pandemic controls. A more detailed characterization of the individuals from whom the pre-pandemic 304 control sera were sampled, as well as the determination of antibody levels in asymptomatic and mild cases 305 could shed further light on this mismatch and thus further improve the estimation of the cumulative incidence. An additional improvement could be obtained when a quantitative immuno-assay would be used, instead of 307 the semi-quantitative Euroimmun that was available at the beginning of the pandemic. "Improving SARS-CoV-2 cumulative incidence estimation through mixture modelling of antibody levels," Assessing the extent of SARS-CoV-2 circulation through serological Validation of a commercially available SARS-CoV-2 369 serological immunoassay Community-Based Surveillance of Cardiovascular 372 Risk Factors in Geneva: Methods, Resulting Distributions, and Comparisons with Other Populations Eleven-year physical activity trends in a Swiss 379 urban area Thirteen-year trends in the prevalence of 382 diabetes in an urban region of Switzerland: a population-based study Respiratory Syndrome Coronavirus 2Specific Antibody Responses in Coronavirus Disease Patients R: A language and environment for statistical computing Association between age and clinical characteristics and outcomes of COVID-19 Male sex identified by global COVID-19 meta-analysis as a risk factor for 396 death and ITU admission Between Measures of Social Distancing and Severe Acute Respiratory Syndrome Coronavirus 2 Seropos-401 itivity: A Nationwide Population-based Study in the Netherlands 404 An alternative, empirically-supported adjustment for sero-reversion yields a 10 percentage point lower 405 estimate of the cumulative incidence of SARS-CoV-2 in Manaus by Immunological memory to SARS-CoV-2 409 assessed for up to 8 months after infection Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 413 infections: A living systematic review and meta-analysis serological assays informs future diagnostics and exposure assessment The authors have no competing interest to declare.